ALL KEYWORDS
Relapsing-Remitting Multiple Sclerosis (RRMS)
Related Specialists
Showing 3 of 24
Related Clinical Trials
Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS)
- Brain, Spinal Cord & Nervous System
- Gender:All Genders
- Age:18 years - 55 years
Identifying and Characterizing Preclinical MS
- Brain, Spinal Cord & Nervous System
- Gender:All Genders
- Age:13 years and older
Related Departments
Showing 3 of 19